Transoral Surgery Versus Radiotherapy as Primary Treatment for HPV-Related Oropharyngeal Cancer in the Elderly

IF 2.2 3区 医学 Q1 OTORHINOLARYNGOLOGY Head and Neck-Journal for the Sciences and Specialties of the Head and Neck Pub Date : 2025-02-07 DOI:10.1002/hed.28097
Andrea Costantino, Bruce Haughey, Jianbin Zhu, Uthman Alamoudi, J. Scott Magnuson
{"title":"Transoral Surgery Versus Radiotherapy as Primary Treatment for HPV-Related Oropharyngeal Cancer in the Elderly","authors":"Andrea Costantino,&nbsp;Bruce Haughey,&nbsp;Jianbin Zhu,&nbsp;Uthman Alamoudi,&nbsp;J. Scott Magnuson","doi":"10.1002/hed.28097","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>This study compares the oncological outcomes of primary transoral surgery (TOS) and primary radiotherapy (RT) in elderly patients with HPV-related oropharyngeal squamous cell carcinoma (OPSCC).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This retrospective cohort study included patients with cT1-2 HPV-related OPSCC from the National Cancer Database (NCDB).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 2566 patients were included, with 73.9% receiving primary RT and 22.3% undergoing primary TOS. Subgroup analysis showed a higher 5-year overall survival (OS) rate for primary TOS (81.6%; 95% CI: 79.6%–83.6%) compared to primary RT (70.7%; 95% CI: 68.3%–73.1%), with an adjusted hazard ratio (HR) of 0.64 (95% CI: 0.50–0.81; <i>p</i> &lt; 0.001) after propensity score matching. Notably, only (13.6%) of patients diagnosed in 2020 underwent primary TOS, with a significant decline over the study period.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>This study suggests that primary TOS may offer better survival outcomes for elderly patients with HPV-related OPSCC compared to primary RT.</p>\n </section>\n </div>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":"47 7","pages":"1867-1877"},"PeriodicalIF":2.2000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hed.28097","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

This study compares the oncological outcomes of primary transoral surgery (TOS) and primary radiotherapy (RT) in elderly patients with HPV-related oropharyngeal squamous cell carcinoma (OPSCC).

Methods

This retrospective cohort study included patients with cT1-2 HPV-related OPSCC from the National Cancer Database (NCDB).

Results

A total of 2566 patients were included, with 73.9% receiving primary RT and 22.3% undergoing primary TOS. Subgroup analysis showed a higher 5-year overall survival (OS) rate for primary TOS (81.6%; 95% CI: 79.6%–83.6%) compared to primary RT (70.7%; 95% CI: 68.3%–73.1%), with an adjusted hazard ratio (HR) of 0.64 (95% CI: 0.50–0.81; p < 0.001) after propensity score matching. Notably, only (13.6%) of patients diagnosed in 2020 underwent primary TOS, with a significant decline over the study period.

Conclusions

This study suggests that primary TOS may offer better survival outcomes for elderly patients with HPV-related OPSCC compared to primary RT.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
经口手术与放疗作为老年人hpv相关口咽癌的主要治疗方法。
背景:本研究比较了原发性经口手术(TOS)和原发性放疗(RT)治疗老年hpv相关口咽鳞状细胞癌(OPSCC)患者的肿瘤预后。方法:这项回顾性队列研究纳入了来自国家癌症数据库(NCDB)的cT1-2 hpv相关OPSCC患者。结果:共纳入2566例患者,73.9%接受了原发性放疗,22.3%接受了原发性TOS。亚组分析显示原发性TOS患者的5年总生存率(OS)更高(81.6%;95% CI: 79.6%-83.6%)与初级RT (70.7%;95% CI: 68.3%-73.1%),校正风险比(HR)为0.64 (95% CI: 0.50-0.81;结论:本研究表明,与原发性RT相比,原发性TOS可能为hpv相关的老年OPSCC患者提供更好的生存结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.00
自引率
6.90%
发文量
278
审稿时长
1.6 months
期刊介绍: Head & Neck is an international multidisciplinary publication of original contributions concerning the diagnosis and management of diseases of the head and neck. This area involves the overlapping interests and expertise of several surgical and medical specialties, including general surgery, neurosurgery, otolaryngology, plastic surgery, oral surgery, dermatology, ophthalmology, pathology, radiotherapy, medical oncology, and the corresponding basic sciences.
期刊最新文献
A Systematic Review of 33 Cases of Branchiogenic Carcinoma: Clinicopathological Features and Prognostic Outcomes. An Automated Framework for Mandibular Reconstruction: Evaluation and Clinical Application. The Submandibular-Facial Artery Perforator Flap (S-FAPF): A Novel Tool for Lower Face Reconstruction. Start Making Sense: Addressing Reported Ambiguity of Final Margin Status for Oral Cavity Cancer. Thyroid Lobectomy for Unilateral Papillary Thyroid Carcinoma Patients With High-Volume (n ≥ 5) Central Lymph Node Metastases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1